HF
OTLK icon

HRT Financial’s Outlook Therapeutics OTLK Stock Holding History

HRT Financial’s Portfolio OTLK Stock Details OTLK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13K Buy
+67,759
New +$29.3K ﹤0.01% 3613
2025
Q3 		– Sell
-35,399
Closed -$56K – 3447
2025
Q2 		$56K Buy
+35,399
New +$56.4K ﹤0.01% 2295
2024
Q2 		– Sell
-28,623
Closed -$341K – 2863
2024
Q1 		$341K Buy
+28,623
New +$231K ﹤0.01% 1482
2022
Q3 		– Sell
-1,006
Closed -$20K – 3309
2022
Q2 		$20K Buy
+1,006
New +$28.9K ﹤0.01% 2606
2021
Q2 		– Sell
-1,434
Closed -$64K – 3339
2021
Q1 		$64K Buy
+1,434
New +$54.9K ﹤0.01% 2516

Other funds holding OTLK

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GWM
Gilpin Wealth Management Denver, Colorado $145M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NMC
Nine Masts Capital Central, Hong Kong $693M AUM 31.93% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return

HRT Financial's OTLK Position: Q1 2026 in Review

HRT Financial opened a new position in Outlook Therapeutics (OTLK) in Q1 2026: 67,759 shares worth $13K. The stake represents ﹤0.01% of the portfolio and ranks #3613 among its holdings. This is a return to the name: HRT Financial previously reported a position in OTLK as recently as Q2 2025.

HRT Financial first reported a position in OTLK in Q1 2021 and has held it in 5 quarters since. The position peaked at $341K in Q1 2024. 54 funds tracked by Wall St. Rank hold OTLK as of Q1 2026.

  • HRT Financial held 67,759 shares of Outlook Therapeutics worth $13K as of Q1 2026.
  • Outlook Therapeutics was a new HRT Financial position in Q1 2026.
  • Outlook Therapeutics made up ﹤0.01% of HRT Financial's portfolio in Q1 2026, its #3613 holding.
  • HRT Financial first reported a position in Outlook Therapeutics in Q1 2021 and has held it in 5 quarters since.
  • HRT Financial's Outlook Therapeutics position peaked at $341K in Q1 2024.
  • 54 funds tracked by Wall St. Rank held Outlook Therapeutics as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.